Product NDC: | 60432-007 |
Proprietary Name: | Cimetidine Hydrochloride |
Non Proprietary Name: | Cimetidine Hydrochloride |
Active Ingredient(s): | 300 mg/5mL & nbsp; Cimetidine Hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 60432-007 |
Labeler Name: | Morton Grove Pharmaceuticals, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA074757 |
Marketing Category: | ANDA |
Start Marketing Date: | 19970312 |
Package NDC: | 60432-007-08 |
Package Description: | 237 mL in 1 BOTTLE (60432-007-08) |
NDC Code | 60432-007-08 |
Proprietary Name | Cimetidine Hydrochloride |
Package Description | 237 mL in 1 BOTTLE (60432-007-08) |
Product NDC | 60432-007 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Cimetidine Hydrochloride |
Dosage Form Name | SOLUTION |
Route Name | ORAL |
Start Marketing Date | 19970312 |
Marketing Category Name | ANDA |
Labeler Name | Morton Grove Pharmaceuticals, Inc. |
Substance Name | CIMETIDINE HYDROCHLORIDE |
Strength Number | 300 |
Strength Unit | mg/5mL |
Pharmaceutical Classes | Histamine H2 Receptor Antagonists [MoA],Histamine-2 Receptor Antagonist [EPC] |